| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Oregon Regional Primate Research Center (X.-B.H., P.M.C.), Oregon Health Sciences University, Beaverton, Oregon 97006; and the Department of Physiology and Pharmacology, Oregon Health Sciences University (P.M.C.), Portland, Oregon 97201
Address all correspondence and requests for reprints to: Dr. P. Michael Conn, 505 NW 185th Avenue, Beaverton, Oregon 97006. E-mail: connm{at}OHSU.edu
There is convincing evidence that mitogen-activated protein kinase
(MAPK) activation is coupled to both receptor tyrosine kinase and G
protein-coupled receptors. The presence of the epidermal growth factor
(EGF) receptor and the GnRH receptor on the surface of
GGH31' cells makes this cell line a good model for the
assessment of MAPK activation by receptor tyrosine kinases and G
protein-coupled receptors. In this study, to assess the activated and
total (i.e. activated plus inactivated) MAPK, the
phosphorylation state of p44 and p42 MAPKs was examined using antisera
that distinguish phospho-p44/42 MAPK
(Thr202/Tyr204) from p44/42 MAPK
(phosphorylation state independent). The data show that both EGF (200
ng/ml) and Buserelin (a GnRH agonist; 10 ng/ml) provoke rapid
activation of MAPK (within 5 and 15 min, respectively) after binding to
their receptors. The role of protein kinase A (PKA) and protein kinase
C (PKC) signal transduction pathways in mediating MAPK activation was
also assessed. Both phorbol ester (phorbol 12-myristate 13-acetate; 10
ng/ml) and (Bu)2cAMP (1 mM) trigger the
phosphorylation of MAPK, suggesting potential roles for PKC and PKA
signaling events in MAPK activation in GGH31' cells.
Treatment of PKC-depleted cells with Buserelin activated MAPK,
suggesting involvement of PKC-independent signal transduction pathways
in MAPK activation in response to GnRH. Similarly, treatment of
PKC-depleted cells with forskolin (50 µM) or cholera
toxin (100 ng/ml) stimulated MAPK activation, whereas pertussis toxin
(100 ng/ml) had no measurable effect. To further assess the role of PKA
in response to EGF and Buserelin, cells were treated with EGF (200
ng/ml) for 3 min or with Buserelin (10 ng/ml) for 10 min after
pretreatment with 3-isobutyl-1-methylxanthine (0.5 mM),
forskolin (50 µM), or (Bu)2cAMP (1
mM) for 15 min. The results show that MAPK can be activated
in a PKA-dependent manner in GGH31' cells. Consistent with
previous reports, the current data support the view that MAPK
activation can be achieved via both PKC- and PKA-dependent signaling
pathways triggered by the GnRH receptor that couples to
Gq/11 and Gs
-subunit proteins. In contrast,
Gi/o
does not appear to participate in MAPK activation
in GGH31' cells.
This article has been cited by other articles:
![]() |
T. B. Salisbury, A. K. Binder, and J. H. Nilson Welcoming {beta}-Catenin to the Gonadotropin-Releasing Hormone Transcriptional Network in Gonadotropes Mol. Endocrinol., June 1, 2008; 22(6): 1295 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Ford, K. V. Wong, V. B. Lu, E. Posse de Chaves, and P. A. Smith Differential Neurotrophic Regulation of Sodium and Calcium Channels in an Adult Sympathetic Neuron J Neurophysiol, March 1, 2008; 99(3): 1319 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
L L Burger, D J Haisenleder, A C Dalkin, and J C Marshall Regulation of gonadotropin subunit gene transcription J. Mol. Endocrinol., December 1, 2004; 33(3): 559 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kraus, O. Benard, Z. Naor, and R. Seger c-Src Is Activated by the Epidermal Growth Factor Receptor in a Pathway That Mediates JNK and ERK Activation by Gonadotropin-releasing Hormone in COS7 Cells J. Biol. Chem., August 29, 2003; 278(35): 32618 - 32630. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Ford, W. F. Dryden, and P. A. Smith Neurotrophic Regulation of Calcium Channels by the Peptide Neurotransmitter Luteinizing Hormone Releasing Hormone J. Neurosci., August 6, 2003; 23(18): 7169 - 7175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chamson-Reig, E. M. Sorianello, P. N. Catalano, M. O. Fernandez, O. P. Pignataro, C. Libertun, and V. A. R. Lux-Lantos Gonadotropin-Releasing Hormone Signaling Pathways in an Experimental Ovarian Tumor Endocrinology, July 1, 2003; 144(7): 2957 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Shah, J.-W. Soh, and K. J. Catt Dependence of Gonadotropin-releasing Hormone-induced Neuronal MAPK Signaling on Epidermal Growth Factor Receptor Transactivation J. Biol. Chem., January 24, 2003; 278(5): 2866 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kanasaki, T. Yonehara, Y. Yamada, K. Takahashi, K. Hata, R. Fujiwaki, H. Yamamoto, Y. Takeuchi, K. Fukunaga, E. Miyamoto, et al. Regulation of Gonadotropin {alpha} Subunit Gene Expression by Dopamine D2 Receptor Agonist in Clonal Mouse Gonadotroph {alpha}T3-1 Cells Biol Reprod, October 1, 2002; 67(4): 1218 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, I. Usui, L. G. Evans, D. A. Austin, P. L. Mellon, J. M. Olefsky, and N. J. G. Webster Involvement of Both Gq/11 and Gs Proteins in Gonadotropin-releasing Hormone Receptor-mediated Signaling in Lbeta T2 Cells J. Biol. Chem., August 23, 2002; 277(35): 32099 - 32108. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Borud, T. Hoang, M. Bakke, A. L. Jacob, J. Lund, and G. Mellgren The Nuclear Receptor Coactivators p300/CBP/Cointegrator-Associated Protein (p/CIP) and Transcription Intermediary Factor 2 (TIF2) Differentially Regulate PKA-Stimulated Transcriptional Activity of Steroidogenic Factor 1 Mol. Endocrinol., April 1, 2002; 16(4): 757 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maya-Nunez and P. Michael Conn Cyclic Adenosine 3',5'-Monophosphate (cAMP) and cAMP Responsive Element-Binding Protein Are Involved in the Transcriptional Regulation of Gonadotropin-Releasing Hormone (GnRH) Receptor by GnRH and Mitogen-Activated Protein Kinase Signal Transduction Pathway in GGH3 Cells Biol Reprod, August 1, 2001; 65(2): 561 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kang, C.-J. Tai, P. S. Nathwani, K.-C. Choi, and P. C. K. Leung Stimulation of Mitogen-Activated Protein Kinase by Gonadotropin-Releasing Hormone in Human Granulosa-Luteal Cells Endocrinology, February 1, 2001; 142(2): 671 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein Mol. Cell. Biol., December 1, 2000; 20(23): 8720 - 8730. [Abstract] [Full Text] |
||||
![]() |
D. K. Grammatopoulos, H. S. Randeva, M. A. Levine, E. S. Katsanou, and E. W. Hillhouse Urocortin, but Not Corticotropin-Releasing Hormone (CRH), Activates the Mitogen-Activated Protein Kinase Signal Transduction Pathway in Human Pregnant Myometrium: An Effect Mediated via R1{{alpha}} and R2{beta} CRH Receptor Subtypes and Stimulation of Gq-Proteins Mol. Endocrinol., December 1, 2000; 14(12): 2076 - 2091. [Abstract] [Full Text] |
||||
![]() |
M. S. Johnson, E. M. Lutz, C. J. MacKenzie, W. B. Wolbers, D. N. Robertson, P. J. Holland, and R. Mitchell Gonadotropin-Releasing Hormone Receptor Activation of Extracellular Signal-Regulated Kinase and Tyrosine Kinases in Transfected GH3 Cells and in {alpha}T3-1 Cells Endocrinology, September 1, 2000; 141(9): 3087 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Andreis, A. Markowska, H. C. Champion, G. Mazzocchi, L. K. Malendowicz, and G. G. Nussdorfer Adrenomedullin Enhances Cell Proliferation and Deoxyribonucleic Acid Synthesis in Rat Adrenal Zona Glomerulosa: Receptor Subtype Involved and Signaling Mechanism Endocrinology, June 1, 2000; 141(6): 2098 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Davis, A. Shih, H.-Y. Lin, L. J. Martino, and F. B. Davis Thyroxine Promotes Association of Mitogen-activated Protein Kinase and Nuclear Thyroid Hormone Receptor (TR) and Causes Serine Phosphorylation of TR J. Biol. Chem., November 22, 2000; 275(48): 38032 - 38039. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |